Synopsis
The guidelines have been developed by working parties of the Australian Cancer Network to address the diagnostic and clinical aspects of the disease. The guidelines provide advice for reducing variability in treatment where appropriate, and for management to include the latest products resulting from pharmacological and biotechnological activity. The need for multidisciplinary teams in the management of patients with lymphoma is also stressed.
Copies of this guideline document can be obtained through the Australian Cancer Network on 02 8063 4141 or email: acn@cancer.org.au.